Showing results (31-40 of 91) with videos related to

Sort By:
Pageof 10
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 12, 2022
Antibiotic resistance associated with the COVID-19 pandemic: a systematic review and meta-analysisBradley J Langford, Jean-Paul R Soucy, Valerie Leung, et al.
Scientific Reports|May 7, 2025
The effect of childhood trauma on bipolar depressionHernán F Guillen-Burgos, Juan F Gálvez-Flórez, Sergio Moreno-López, et al.
CNS Spectrums|December 27, 2024
Anatomical, behavioral, and cognitive teratogenicity associated with valproic acid: a systematic reviewKyle Valentino, Kayla M Teopiz, Angela T H Kwan, et al.
Journal of Affective Disorders|July 19, 2024
A replication study using the World Health Organization pharmacovigilance database (VigiBase®) to evaluate whether an association between ketamine and esketamine and alcohol and substance misuse existsAngela T H Kwan, Joshua D Rosenblat, Rodrigo B Mansur, et al.
Journal of Affective Disorders|October 21, 2024
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: A replication study using reports to the World Health Organization pharmacovigilance database (VigiBase®)Roger S McIntyre, Rodrigo B Mansur, Joshua D Rosenblat, et al.
International Clinical Psychopharmacology|May 10, 2024
Risk of VMAT2 inhibitors on suicidality and parkinsonism: report utilizing the United States Food and Drug Administration adverse event reporting systemSabrina Wong, Gia Han Le, Angela T H Kwan, et al.
Drug Metabolism Reviews|April 24, 2024
Effects of cannabidiol and Δ9-tetrahydrocannabinol on cytochrome P450 enzymes: a systematic reviewSarah Ann Smith, Gia Han Le, Kayla M Teopiz, et al.
Expert Opinion on Drug Safety|May 28, 2024
Association between dual orexin receptor antagonists (DORAs) and suicidality: reports to the United States Food and Drug Administration Adverse Event Reporting System (FAERS)Roger S McIntyre, Sabrina Wong, Angela T H Kwan, et al.
Journal of Affective Disorders|April 18, 2024
Number needed to treat (NNT) for ketamine and esketamine in adults with treatment-resistant depression: A systematic review and meta-analysisCameron N Calder, Angela T H Kwan, Kayla M Teopiz, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|February 6, 2024
Impact of vortioxetine on psychosocial functioning moderated by symptoms of fatigue in post-COVID-19 condition: a secondary analysisSebastian Badulescu, Gia Han Le, Sabrina Wong, et al.
Pageof 10